Valeant To Sell Dendreon Pharmaceuticals to China’s Sanpower for $820 Million
By
Valeant Pharmaceuticals has agreed to sell all of the outstanding equity interests in Dendreon Pharmaceuticals, headquartered in Seattle, Washington, to the Sanpower Group, a privately owned business conglomerate based in…